Robert Spitzer on DSM-III: A Recently Recovered Interview
Robert Spitzer, chair of the Task Force for DSM-III, discusses his decisions on inclusion, exclusion, and renaming disorders in the manual.
Stay updated with breaking news from Murray Stein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Robert Spitzer, chair of the Task Force for DSM-III, discusses his decisions on inclusion, exclusion, and renaming disorders in the manual.
Bionomics Limited, a clinical-stage biopharmaceutical company, announced that it has initiated its Phase 2 clinical trial (the PREVAIL Study) to evaluate - eTurboNews | Trends | Travel News
/PRNewswire/ -- Bionomics Limited (ASX: BNO, NASDAQ: BNOX) (Bionomics or Company), a clinical-stage biopharmaceutical company, is pleased to announce that it...
Bionomics Limited (ASX: BNO, NASDAQ: BNOX) ( Bionomics or Company ), a clinical-stage biopharmaceutical company, is pleased to announce that it has initiated its Phase 2 clinical
Fifty-one faculty members and researchers at the University of California San Diego have been cited as among the world’s most influential in their fields, according to the 2021 Clarivate listing of Most Highly Cited Researchers in the World.Clarivate